Navigation Links
The Use Of Testosterone Replacement Therapy Questioned

Symptoms of low levels of testosterone include erectile dysfunction, reduced muscle mass, reduced bone density, depression, and anemia.// Testosterone replacement therapy is designed to increase testosterone levels for men with the condition. The therapy may be offered as an injection, patch, gel, or tablet. New research shows testosterone replacement therapy does not increase a man’s risk of developing prostate cancer or heart disease. However the side effects of testosterone replacement therapy include acne, sleep apnea, fluid retention, and infertility.

Researchers reviewed more than 70 studies that examined the safety of testosterone replacement therapy. Results show the therapy was not associated with an increased risk of prostate cancer or cardiovascular disease. Previous studies have shown extremely low levels of testosterone can shrink prostate cancer that has spread. That’s why some have raised concern over increasing testosterone levels in men who are deficient. However, researchers of the current study point out that prostate cancer becomes more prevalent when testosterone levels decline. They found no connection between high testosterone levels and prostate cancer.

Though testosterone is believed to be a risk factor for cardiovascular disease because men, who have higher levels of the hormone, are more likely to have a cardiac event than women , researchers say there is little evidence to support this assumption. Thus they conclude saying that testosterone is only for men who have symptoms of low testosterone combined with a confirmatory blood test and testosterone therapy can be beneficial and safe for these men as long as they are appropriately monitored by their physician.
'"/>




Page: 1

Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. Depression In Men Could Be To Low Testosterone Levels
4. Testosterone patch for women Rejected For safety Reasons
5. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
6. Testosterone Therapy can improve sexual function in postmenopausal women
7. Fatherhood Found To Tame Men by Reducing Testosterone Levels
8. Testosterone levels could serve as a marker for determining risk of SIDS
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2016)... IL (PRWEB) , ... February 06, 2016 , ... ... recovery phases of eating disorder treatment helps to reduce the frequency and level ... of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe ... signed a joint enrollment and degree completion agreement. The agreement, which begins ... degrees at FHU|Dickson. , The agreement allows students to be jointly admitted ...
(Date:2/5/2016)... ... ... The American public tends to feel uncomfortable about drinking recycled waste water ... well water. The recent experience with lead contaminated water in Flint, Michigan, according to ... increasing public acceptance of recycled waste water as drinking water. , The Flint ...
(Date:2/5/2016)... , ... February 05, 2016 , ... At its annual ... Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds former ... the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat has ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: